Sign Up
OverviewAPI
The global market for immunoglobulin, immuno-oncology drugs, cancer immunotherapy, and immuno-oncology assays is experiencing significant growth, driven by factors such as increasing cancer prevalence, R&D investments, and technological advancements. North America leads in revenue share across these markets, with Asia-Pacific showing high growth potential. Key players in these markets include CSL Limited, AbbVie Inc., Bristol Myers Squibb, and Luminex Corporation.

Ask a question